Halozyme Therapeutics shares owned by Brandywine Global Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Brandywine Global Investment Management
from 13F filings
Historical chart of Brandywine Global Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Brandywine Global Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Brandywine Global Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $5.5M | 82k | 67.30 |
| 2025-09-30 | $5.4M | 73k | 73.34 |
| 2025-06-30 | $3.8M | 73k | 52.02 |
| 2025-03-31 | $4.8M | 75k | 63.81 |
More positions owned by Brandywine Global Investment Management
View all positions for Brandywine Global Investment Management